Related references
Note: Only part of the references are listed.Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo
Abrar K. Thabit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline
Ravi Shankar Prasad Singh et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Assessment of Minocycline and Polymyxin B Combination against Acinetobacter baumannii
Dana R. Bowers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Determination of Atypical Nonlinear Plasma-Protein-Binding Behavior of Tigecycline Using an In Vitro Microdialysis Technique
Jatinder Kaur Mukker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Protein binding of cefazolin is saturable in vivo both between and within patients
Jane W. A. Vella-Brincat et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects
G Muralidharan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)